| Date Filed | Type | Description |
| 10/13/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/03/2023 |
8-K
| Quarterly results |
| 08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/29/2023 |
11-K
| Form 11-K - Annual report of employee stock purchase, savings and similar plans: |
| 05/05/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/05/2023 |
8-K
| Quarterly results |
| 05/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/01/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/28/2023 |
8-K
| Quarterly results |
| 04/27/2023 |
8-K
| Quarterly results |
| 04/24/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/17/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/13/2023 |
PX14A6G
| Form PX14A6G - Notice of exempt solicitation submitted by non-management: |
| 03/17/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 03/17/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 03/17/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/07/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"$700,000,000 5.685% Senior Notes due 2026 $800,000,000 5.400% Senior Notes due 2033 Underwriting Agreement",
"SUPPLEMENTAL INDENTURE NO. 6 THIS SUPPLEMENTAL INDENTURE NO. 6, dated as of March 7, 2023 , between THE CIGNA GROUP, a corporation duly organized and existing under the laws of the State of Delaware , and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, a national banking association duly organized and existing under the laws of the United States of America, as successor to U.S. Bank National Association, as trustee . RECITALS OF THE COMPANY: WHEREAS, the Company and the Trustee are parties to an Indenture, dated as of September 17, 2018 , relating to the issuance from time to time by the Company of its Securities on terms to be specified at the time of issuance; WHEREAS, Section 9.01 of the Base Indenture provides that the Company may enter into a supplemental indenture to establish the ter...",
"Simpson Thacher & Bartlett llp" |
|
| 03/06/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 03/02/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 02/28/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 02/27/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 02/23/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/14/2023 |
SC 13G/A
| DODGE & COX reports a 3.8% stake in Cigna Corporation |
| 02/14/2023 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a 4.5% stake in Cigna Corp |
| 02/13/2023 |
8-K
| Quarterly results |
| 02/09/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/07/2023 |
SC 13G
| BlackRock Inc. reports a 9% stake in Cigna Corporation |
| 02/03/2023 |
8-K
| Quarterly results |
|